• Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)
    • Services
      • Equity Reports (Analyst-Ready)
      • Visibility Upgrades (Quartely + As needed)
      • Investor Mapping
    • Press
    • Ask AI
    • Contact
    • English
      • Deutsch (German)
      • 日本語 (Japanese)
  • info@vasro.de
  • +49 (0)69 90 28 39 81
  • Call us Mon - Fri: 8:30 AM - 6:00 PM
VASRO GmbH
VASRO GmbH
  • Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)

Press

VASRO GmbH > Press
VASRO GmbH

Lithium vs. Hydrogen: The Battle for the Future of Heavy Transport

  • December 24, 2025
  • Energy
Lithium vs. Hydrogen: Which powers the future of heavy transport? Compare range, refueling, and infrastructure to see which technology leads today.
Continue Reading
VASRO GmbH

Asian Family Offices: The New “Whales” of Small-Cap Financing

  • December 23, 2025
  • Unkategorisiert
Asian Family Offices now drive small-cap financing, offering patient capital, strategic influence, and new opportunities for investors and startups.
Continue Reading
VASRO GmbH

NI 43-101 vs. JORC Code: Understanding Mining Technical Reports for Global Investors

  • December 22, 2025
  • Unkategorisiert
NI 43-101 vs. JORC Code: Compare mining technical reports, disclosure standards, and investor protections for informed global mining investment decisions.
Continue Reading
Tesla’s Battery Tech: Who Provides the Lithium and Cobalt?

Tesla’s Battery Tech: Who Provides the Lithium and Cobalt?

  • December 19, 2025
  • Commodity, Tech
Tesla’s Battery Tech relies on lithium from Albemarle, Ganfeng, Livent and cobalt from Glencore, Vale, plus recycling by Redwood Materials.
Continue Reading
The IR Cadence Playbook: What Goes Out When, and Who Owns It Internally

The IR Cadence Playbook: What Goes Out When, and Who Owns It Internally

  • December 18, 2025
  • Market Intelligence
The IR Cadence Playbook details what goes out when, who owns each step, and how structured timing and roles drive effective incident response.
Continue Reading
MiFID II and its impact on research distribution

MiFID II and its impact on research distribution

  • December 17, 2025
  • Energy, Commodity, Real Estate, Pharma & Biotech, Tech
MiFID II reshapes research distribution by unbundling costs, boosting transparency, and challenging providers to adapt, impacting access and quality for all.
Continue Reading
The Nvidia Effect: Identifying Small-Cap Suppliers in the AI Chip Ecosystem

The Nvidia Effect: Identifying Small-Cap Suppliers in the AI Chip Ecosystem

  • December 16, 2025
  • Tech
The Nvidia Effect drives growth for small-cap suppliers in the AI chip ecosystem. See how to identify promising companies benefiting from Nvidia’s leadership.
Continue Reading
The Next Generation of GLP-1 Weight Loss

The Next Generation of GLP-1 Weight Loss

  • December 15, 2025
  • Pharma & Biotech
Next generation GLP-1 weight loss stocks offer new investment opportunities as advanced therapies, market leaders, and emerging players reshape obesity care.
Continue Reading
VASRO GmbH

Accessing US Retail Capital: A Guide to the OTCQB Market for Foreign Issuers

  • December 12, 2025
  • Energy, Commodity, Real Estate, Pharma & Biotech, Tech
Foreign issuers can access US retail capital by listing on OTCQB, meeting eligibility, and maintaining compliance for broader investor engagement.
Continue Reading
VASRO GmbH

GEMS Scheme and its impact on research funding

  • December 11, 2025
  • Unkategorisiert
GEMS Scheme boosts research funding and coverage for under-researched companies, enhancing market intelligence and investor engagement in Singapore.
Continue Reading

Posts pagination

Previous 1 … 5 6 7 … 37 Next

Search

Categories

  • Energy
  • Equity Analysis reports
  • Equity Research Coverage
  • Market Intelligence
  • Pharma & Biotech
  • Tech
  • Unkategorisiert

Recent Posts

Sirnaomics Ltd.: The RNAimmune Money Is In, and the FDA Has Answered in Writing on STP705 October 12, 2026
Ainos, Inc.: A Partner Pays for VELDONA, and Ainos Keeps the Platform September 29, 2026
Ainos Inc: A Front-End Customer Starts Ordering, and the Dataset Passes a Billion September 16, 2026
Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026
Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026
VASRO GmbH
VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Discover More

Contact Info

  • Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
  • +49 (0)69 90 28 39 81
  • info@vasro.de
  • 8:30 AM - 6:00 PM

Navigation

  • Imprint
  • Privacy Policy
  • Change privacy settings
  • Application
  • About
  • FAQ

©copyright 2025 VASRO GmbH.